Options
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
Date Issued
2016
Author(s)
DOI
10.1186/s40478-016-0352-1
File(s)
No Thumbnail Available
Name
40478_2016_Article_352.pdf
Size
2.36 MB
Checksum (MD5)
d19cb7fc194926d461112646e5b85bd3
